1510 related articles for article (PubMed ID: 16643491)
1. Metabolic abnormalities associated with calyceal diverticular stones.
Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
[TBL] [Abstract][Full Text] [Related]
2. Metabolic abnormalities in patients with caliceal diverticular calculi.
Hsu TH; Streem SB
J Urol; 1998 Nov; 160(5):1640-2. PubMed ID: 9783922
[TBL] [Abstract][Full Text] [Related]
3. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
Ekeruo WO; Tan YH; Young MD; Dahm P; Maloney ME; Mathias BJ; Albala DM; Preminger GM
J Urol; 2004 Jul; 172(1):159-63. PubMed ID: 15201761
[TBL] [Abstract][Full Text] [Related]
4. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney.
Yagisawa T; Kobayashi C; Hayashi T; Yoshida A; Toma H
Am J Kidney Dis; 2001 Jun; 37(6):1140-3. PubMed ID: 11382681
[TBL] [Abstract][Full Text] [Related]
5. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
6. Caliceal diverticular calculi: is there a role for metabolic evaluation?
Liatsikos EN; Bernardo NO; Dinlenc CZ; Kapoor R; Smith AD
J Urol; 2000 Jul; 164(1):18-20. PubMed ID: 10840415
[TBL] [Abstract][Full Text] [Related]
7. Metabolic abnormalities associated with renal calculi in patients with horseshoe kidneys.
Raj GV; Auge BK; Assimos D; Preminger GM
J Endourol; 2004 Mar; 18(2):157-61. PubMed ID: 15072623
[TBL] [Abstract][Full Text] [Related]
8. [Functional evaluation in patients with kidney calculi].
Stojimirović B
Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
[TBL] [Abstract][Full Text] [Related]
9. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
[TBL] [Abstract][Full Text] [Related]
10. Acetazolamide is an effective adjunct for urinary alkalization in patients with uric acid and cystine stone formation recalcitrant to potassium citrate.
Sterrett SP; Penniston KL; Wolf JS; Nakada SY
Urology; 2008 Aug; 72(2):278-81. PubMed ID: 18533229
[TBL] [Abstract][Full Text] [Related]
11. [Metabolic changes in 2612 patients with nephrolithiasis].
del Valle E; Spivacow R; Zanchetta JR
Medicina (B Aires); 1999; 59(5 Pt 1):417-22. PubMed ID: 10684159
[TBL] [Abstract][Full Text] [Related]
12. Screening for biochemical abnormalities in urolithiasis patients.
Orakzai N; Hanbury DC; Farrington K
J Ayub Med Coll Abbottabad; 2004; 16(2):60-3. PubMed ID: 15455621
[TBL] [Abstract][Full Text] [Related]
13. Pediatric urolithiasis--evaluation of risk factors in 95 children.
Erbagci A; Erbagci AB; Yilmaz M; Yagci F; Tarakcioglu M; Yurtseven C; Koyluoglu O; Sarica K
Scand J Urol Nephrol; 2003; 37(2):129-33. PubMed ID: 12745721
[TBL] [Abstract][Full Text] [Related]
14. [Sodium excretion in children with lithogenic disorders].
Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
[TBL] [Abstract][Full Text] [Related]
15. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study.
Borghi L; Meschi T; Amato F; Briganti A; Novarini A; Giannini A
J Urol; 1996 Mar; 155(3):839-43. PubMed ID: 8583588
[TBL] [Abstract][Full Text] [Related]
16. [Studies of urinary risk factors in urolithiasis].
Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm followup study.
Lee YH; Huang WC; Tsai JY; Huang JK
J Urol; 1999 May; 161(5):1453-7. PubMed ID: 10210371
[TBL] [Abstract][Full Text] [Related]
18. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of factors involved in calcium stone formation.
Abraham PA; Smith CL
Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
